In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Taiwan Liposome Seeks To Teach Old Drugs New Tricks In China And Markets Far From Home

This article was originally published in PharmAsia News

Executive Summary

Taiwan Liposome Co. Ltd. has the funds and team to reach outside of its base in Taiwan to turn old drugs into new products and is looking for opportunities at Asia-specific product applications.

You may also be interested in...

Sandoz, Taiwan’s TLC Ink Commercialization Deal For AmBisome Generic In U.S., EU

Sandoz will commercialize TLC’s liposomal amphotericin B product, a generic of Gilead’s AmBisome, in the U.S. and EU.

Emerging Company In An Emerging Market: Generon Sees Quality And Price As Litmus Test

Generon in Shanghai was founded by former Hutchison MediPharma employees to target a niche market between expensive import drugs and lower quality domestic products.

Meet China’s New Innovators: Haixi Pharma Appoints Beta Pharma Alum To Build Biotech From Scratch

CEO Jason Kang, former chief scientist at Beta Pharma, is building a pipeline of Class I molecules with experience on what it takes to build a start-up company in China.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts